Roopa Industries Ltd
Incorporated in 1985, Roopa Industries Ltd does manufacturing and marketing of bulk drugs and intermediaries
- Market Cap ₹ 45.3 Cr.
- Current Price ₹ 57.6
- High / Low ₹ 73.2 / 37.4
- Stock P/E 29.8
- Book Value ₹ 19.7
- Dividend Yield 0.00 %
- ROCE 13.0 %
- ROE 10.3 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 63.0 to 43.3 days.
Cons
- Stock is trading at 2.97 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 9.71% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
32.12 | 28.55 | 30.98 | 30.60 | 29.97 | 18.94 | 30.15 | 27.65 | 28.61 | 51.21 | 76.17 | 70.43 | |
30.49 | 28.75 | 28.85 | 31.47 | 27.73 | 21.57 | 27.65 | 25.82 | 25.89 | 47.77 | 72.28 | 65.88 | |
Operating Profit | 1.63 | -0.20 | 2.13 | -0.87 | 2.24 | -2.63 | 2.50 | 1.83 | 2.72 | 3.44 | 3.89 | 4.55 |
OPM % | 5.07% | -0.70% | 6.88% | -2.84% | 7.47% | -13.89% | 8.29% | 6.62% | 9.51% | 6.72% | 5.11% | 6.46% |
0.06 | 0.06 | -0.07 | 3.11 | 0.22 | 4.65 | 0.28 | 1.09 | 0.08 | 0.06 | 0.65 | 1.13 | |
Interest | 0.82 | 1.22 | 1.35 | 1.46 | 1.52 | 1.05 | 1.42 | 1.36 | 1.06 | 1.21 | 1.84 | 2.63 |
Depreciation | 0.57 | 0.59 | 0.53 | 0.52 | 0.51 | 0.52 | 0.57 | 0.76 | 0.81 | 0.93 | 0.89 | 0.87 |
Profit before tax | 0.30 | -1.95 | 0.18 | 0.26 | 0.43 | 0.45 | 0.79 | 0.80 | 0.93 | 1.36 | 1.81 | 2.18 |
Tax % | 43.33% | -3.08% | 11.11% | 34.62% | 55.81% | -22.22% | 24.05% | 53.75% | 23.66% | 25.74% | 24.86% | 29.82% |
0.18 | -2.01 | 0.16 | 0.17 | 0.19 | 0.54 | 0.60 | 0.37 | 0.72 | 1.02 | 1.35 | 1.52 | |
EPS in Rs | 0.23 | -2.56 | 0.20 | 0.22 | 0.24 | 0.69 | 0.76 | 0.47 | 0.92 | 1.30 | 1.72 | 1.93 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 18% |
3 Years: | 35% |
TTM: | -8% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 21% |
3 Years: | 28% |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 41% |
3 Years: | 59% |
1 Year: | 40% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 8% |
3 Years: | 10% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
Reserves | 2.63 | 0.62 | 0.79 | 0.96 | 1.50 | 1.95 | 2.56 | 2.93 | 3.70 | 4.72 | 6.08 | 7.61 |
6.35 | 7.89 | 8.37 | 8.42 | 11.25 | 15.97 | 15.08 | 13.51 | 13.46 | 11.97 | 18.88 | 25.86 | |
6.50 | 7.49 | 8.49 | 8.01 | 8.19 | 9.53 | 10.96 | 13.88 | 21.31 | 24.47 | 23.72 | 23.44 | |
Total Liabilities | 23.35 | 23.87 | 25.52 | 25.26 | 28.81 | 35.32 | 36.47 | 38.19 | 46.34 | 49.03 | 56.55 | 64.78 |
7.10 | 8.13 | 7.60 | 6.91 | 6.76 | 6.29 | 6.30 | 10.53 | 10.36 | 9.69 | 9.98 | 8.74 | |
CWIP | 1.37 | 0.02 | 0.04 | 0.02 | 0.03 | 2.39 | 4.49 | 0.00 | 0.10 | 0.69 | 0.88 | 0.88 |
Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.16 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
14.84 | 15.68 | 17.84 | 18.29 | 21.86 | 26.62 | 25.67 | 27.65 | 35.87 | 38.64 | 45.68 | 55.14 | |
Total Assets | 23.35 | 23.87 | 25.52 | 25.26 | 28.81 | 35.32 | 36.47 | 38.19 | 46.34 | 49.03 | 56.55 | 64.78 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.88 | 0.66 | 0.60 | 1.27 | -1.17 | -4.53 | 4.42 | 2.44 | -0.52 | 2.34 | 8.91 | -0.97 | |
-0.65 | -0.26 | -0.13 | 0.19 | -0.45 | 2.50 | -2.43 | 0.70 | 1.34 | 3.65 | -0.99 | 1.11 | |
0.87 | -0.41 | -0.40 | -1.49 | 1.56 | 2.05 | -1.88 | -3.06 | -0.58 | -5.01 | -7.47 | 0.99 | |
Net Cash Flow | -0.66 | -0.01 | 0.08 | -0.02 | -0.07 | 0.02 | 0.11 | 0.08 | 0.25 | 0.99 | 0.45 | 1.14 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 81.36 | 88.09 | 65.98 | 98.65 | 146.39 | 232.61 | 134.01 | 157.09 | 146.71 | 111.76 | 33.93 | 43.27 |
Inventory Days | 86.04 | 94.14 | 143.15 | 70.02 | 139.15 | 217.36 | 171.17 | 256.27 | 409.39 | 140.50 | 109.12 | 168.13 |
Days Payable | 93.27 | 117.63 | 132.29 | 100.12 | 121.54 | 176.51 | 122.79 | 219.33 | 279.59 | 86.37 | 42.21 | 95.83 |
Cash Conversion Cycle | 74.14 | 64.60 | 76.84 | 68.55 | 164.00 | 273.45 | 182.39 | 194.02 | 276.52 | 165.89 | 100.84 | 115.58 |
Working Capital Days | 78.52 | 76.71 | 87.07 | 102.58 | 156.74 | 306.99 | 156.65 | 168.31 | 172.74 | 93.51 | 81.37 | 116.14 |
ROCE % | 7.27% | -4.45% | 10.00% | 10.04% | 10.30% | 5.86% | 8.58% | 8.67% | 8.07% | 10.36% | 12.72% |
Documents
Announcements
- Closure of Trading Window 25 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Submission of Newspaper clippings w.r.t publication of financial results As per Regulation 47 of SEBI (LODR) Regulations, 2015
- Submission Of Audited Financial Results For 4Th Quarter And Financial Year Ended 31 March 2024 30 May
- Board Meeting Outcome for Outcome Of Board Meeting 30 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
25 May - Submission of Annual Secretarial Compliance Report for the Financial Year ended 31 March 2024
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1] Company manufacturers Active Pharma Ingredient(API), Pharmaceutical Intermediate, Nutraceuticals, bulk drugs, fine chemicals and has been a principal supplier to companies in various countries